Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 215,571 |
|
|||||
| News | - | ||||||
| Day High | 2.94 | Low High |
|||||
| Day Low | 2.522 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Inotiv Inc | NOTV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.36 | 14.57% | 2.83 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.54 | 2.522 | 2.94 | 2.92 | 2.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,641 | 215,571 | $ 2.79 | $ 601,459 | - | 1.61 - 8.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:51:50 | 1 | $ 2.84 | USD |
Inotiv Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 75.54M | 25.78M | - | 547.66M | -306.13M | -11.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Inotiv News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NOTV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.37 | 2.94 | 2.345 | 2.57 | 219,303 | 0.46 | 19.41% |
| 1 Month | 1.84 | 2.94 | 1.61 | 2.14 | 208,477 | 0.99 | 53.8% |
| 3 Months | 3.28 | 3.41 | 1.61 | 2.43 | 213,446 | -0.45 | -13.72% |
| 6 Months | 6.14 | 7.50 | 1.61 | 4.48 | 389,876 | -3.31 | -53.91% |
| 1 Year | 6.12 | 8.88 | 1.61 | 5.41 | 505,821 | -3.29 | -53.76% |
| 3 Years | 15.83 | 60.66 | 1.61 | 12.93 | 350,448 | -13.00 | -82.12% |
| 5 Years | 15.83 | 60.66 | 1.61 | 12.93 | 350,448 | -13.00 | -82.12% |
Inotiv Description
| Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products. |
